Charles Schwab Investment Management Inc Syndax Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 635,207 shares of SNDX stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

635,207

Previous 577,022 10.08%

Holding current value

$13 Million

Previous $12.5 Million 21.24%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$19.71 - $24.57 $1.15 Million - $1.43 Million	58,185 Added 10.08%	635,207 $15.1 Million
Q4 2023 Feb 06, 2024	BUY	$11.39 - $21.67 $803,621 - $1.53 Million	70,555 Added 13.93%	577,022 $12.5 Million
Q3 2023 Nov 08, 2023	BUY	$14.52 - $21.77 $220,065 - $329,946	15,156 Added 3.08%	506,467 $7.35 Million
Q2 2023 Aug 09, 2023	BUY	$19.35 - $22.31 $409,155 - $471,744	21,145 Added 4.5%	491,311 $10.3 Million
Q1 2023 May 11, 2023	BUY	$20.66 - $28.98 $442,640 - $620,896	21,425 Added 4.77%	470,166 $9.93 Million

Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $1.31 Million - $1.67 Million	63,620 Added 16.52%	448,741 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $522,278 - $699,474	28,216 Added 7.91%	385,121 $9.26 Million
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $212,797 - $303,907	15,601 Added 4.57%	356,905 $6.87 Million
Q1 2022 May 13, 2022	BUY	$14.84 - $22.15 $523,970 - $782,072	35,308 Added 11.54%	341,304 $5.93 Million
Q4 2021 Feb 11, 2022	BUY	$15.23 - $22.47 $52,832 - $77,948	3,469 Added 1.15%	305,996 $6.7 Million
Q3 2021 Nov 16, 2021	BUY	$13.87 - $19.8 $456,267 - $651,340	32,896 Added 12.2%	302,527 $5.78 Million
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $519,327 - $974,415	38,698 Added 16.76%	269,631 $4.63 Million
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $703,045 - $896,674	36,465 Added 18.75%	230,933 $5.16 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $164,590 - $288,196	10,900 Added 5.94%	194,468 $4.33 Million
Q3 2020 Nov 13, 2020	BUY	$13.39 - $17.48 $1.57 Million - $2.05 Million	117,149 Added 176.38%	183,568 $2.71 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $95,309 - $223,667	10,661 Added 19.12%	66,419 $985,000
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $37,200 - $67,295	5,594 Added 11.15%	55,758 $612,000
Q2 2019 Aug 09, 2019	BUY	$4.9 - $9.31 $63,440 - $120,536	12,947 Added 34.79%	50,164 $468,000
Q1 2019 May 14, 2019	BUY	$4.26 - $6.86 $35,507 - $57,178	8,335 Added 28.86%	37,217 $196,000
Q4 2018 Feb 14, 2019	BUY	$3.6 - $8.42 $16,920 - $39,574	4,700 Added 19.44%	28,882 $129,000
Q3 2018 Nov 13, 2018	SELL	$6.33 - $8.08 $1,379 - $1,761	-218 Reduced 0.89%	24,182 $196,000
Q3 2017 Nov 13, 2017	BUY	$10.9 - $12.73 $265,960 - $310,612	24,400	24,400 $286,000

Others Institutions Holding SNDX

# of Institutions

195

Shares Held

90M

Call Options Held

353K

Put Options Held

207K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.16B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Syndax Pharmaceuticals Inc Transaction History